Reconciliation of Movements in Consolidated Equity Shareholders' Funds
for the year ended 31 December 2004
| £m | |||
| Notes | Year to 31 December 2004 |
Year to 31 December 2003 (Restated)* |
|
| Total recognised gains and losses for the year | 625 |
449 |
|
| Dividends paid and proposed | 4 |
(182) |
(166) |
443 |
283 |
||
| Issue of new capital | 27 |
– |
37 |
| Shares issued under share incentive schemes | 27 |
15 |
4 |
| Net sale of shares held in ESOP Trusts and Policyholders’ funds | 27 |
33 |
6 |
| Net increase/(decrease) in equity shareholders’ funds | 491 |
330 |
|
| Equity shareholders’ funds at the beginning of the year | 2,754 |
2,424 |
|
| Equity shareholders’ funds at the end of the year | 3,245 |
2,754 |
* Comparative figures have been restated to reflect the adoption of Urgent Issues Taskforce Abstract 38 “Accounting for ESOP Trusts”. The effects of this restatement are reductions in equity shareholders’ funds at 31 December 2004 and 31 December 2003 of £127 million (R1,380 million) and £109 million (R1,301 million) respectively, representing the original cost of these shares of £143 million (R1,380 million) (2003: £136 million (R1,301 million)) less cumulative foreign exchange losses of £16 million (Rnil) (2003: £27 million (Rnil)). Details of the changes are set out in notes 1, 3 and 27.
